Chemoprevention Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials

被引:4
|
作者
Salazar, Ana S. [1 ]
Rakhmankulova, Malika [1 ]
Simon, Laura E. [2 ]
Toriola, Adetunji T. [1 ]
机构
[1] Washington Univ, Dept Surg, Div Publ Hlth Sci, Sch Med, St Louis, MO 63110 USA
[2] Washington Univ, Bernard Becker Med Lib, Sch Med, St Louis, MO 63110 USA
基金
美国国家卫生研究院;
关键词
CANCER RISK; YOUNG-WOMEN; ASSOCIATION; MENOPAUSE; TAMOXIFEN; THERAPY; TIME;
D O I
10.1093/jncics/pkaa125
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Higher mammographic breast density (MBD) is associated with an increased risk of breast cancer when compared with lower MBD, especially in premenopausal women. However, little is known about the effectiveness of chemoprevention agents in reducing MBD in premenopausal women without a history of breast cancer. Findings from this review should provide insight on how to target MBD in breast cancer prevention in premenopausal women with dense breasts. Methods: We searched 9 electronic databases for clinical trials in English, Spanish, French, or German published until January 2020. Articles evaluating the association of pharmacological agents and MBD were included. Data were extracted on methods, type and dose of intervention, outcomes, side effects, and follow up. Quality of the studies was assessed using the US Preventive Services Task Force criteria. Results: We identified 7 clinical trials evaluating the associations of 6 chemoprevention agents with changes in MBD in premenopausal women without history of breast cancer. The studies evaluated selective estrogen-receptor modulators (n=1); gonadotropin-releasing hormone agonists (n=2); isoflavones (n=1); vitamin D (n=1); and Boswellia, betaine, and mayo-inositol compound (n=1). Hormonal interventions were associated with net reductions in percent density (tamoxifen [13.4%], leuprolide acetate [8.9%], and goserelin [2.7%]), whereas nonhormonal (vitamin D and isoflavone) interventions were not. However, MBD returned to preintervention baseline levels after cessation of gonadotropin-releasing hormone agonists. Conclusions: A limited number of chemoprevention agents have been shown to reduce MBD in premenopausal women. Identification of new and well-tolerated chemoprevention agents targeting MBD and larger studies to confirm agents that have been studied in small trials are urgent priorities for primary breast cancer prevention in premenopausal women with dense breasts.
引用
下载
收藏
页数:9
相关论文
共 50 条
  • [1] RE: Chemopreventive Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials
    Hopper, John L.
    Nguyen, Tuong L.
    Li, Shuai
    JNCI CANCER SPECTRUM, 2021, 5 (04)
  • [2] RE: Chemopreventive Agents to Reduce Mammographic Breast Density in Premenopausal Women: A Systematic Review of Clinical Trials Reply
    Salazar, Ana S.
    Toriola, Adetunji T.
    JNCI CANCER SPECTRUM, 2021, 5 (04)
  • [3] Medication use to reduce mammographic breast density in premenopausal women: A systematic review
    Salazar, Ana S.
    Rakhmankulova, Malika
    Simmon, Laura E.
    Toriola, Adetunji
    CANCER RESEARCH, 2020, 80 (04)
  • [4] Lipidome of mammographic breast density in premenopausal women
    Kayla R. Getz
    Myung Sik Jeon
    Chongliang Luo
    Jingqin Luo
    Adetunji T. Toriola
    Breast Cancer Research, 25
  • [5] Lipidome of mammographic breast density in premenopausal women
    Getz, Kayla R.
    Jeon, Myung S.
    Luo, Chongliang
    Luo, Jingqin
    Toriola, Adetunji T.
    CANCER RESEARCH, 2023, 83 (07)
  • [6] Lipidome of mammographic breast density in premenopausal women
    Getz, Kayla R.
    Jeon, Myung Sik
    Luo, Chongliang
    Luo, Jingqin
    Toriola, Adetunji T.
    BREAST CANCER RESEARCH, 2023, 25 (01)
  • [7] Aspirin Metabolites and Mammographic Breast Density in Premenopausal Women
    Singh, Ramkrishna K.
    Getz, Kayla R.
    Kyeyune, Joy K.
    Jeon, Myung S.
    Luo, Chongliang
    Luo, Jingqin
    Toriola, Adetunji T.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (08) : 1126 - 1128
  • [8] Coffee, Tea, and Mammographic Breast Density in Premenopausal Women
    Odama, Adashi Margaret
    Otti, Valerie
    Xu, Shuai
    Adebayo, Olamide
    Toriola, Adetunji T.
    NUTRIENTS, 2021, 13 (11)
  • [9] The effects of raloxifene on mammographic breast density: a review of clinical trials
    Pearman, Leny
    Kagan, Risa
    Arsenault, Jody
    Muram, David
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (03): : 654 - 659
  • [10] Family History of Breast Cancer and Mammographic Breast Density in Premenopausal Women
    Han, Yunan
    Moore, Justin Xavier
    Colditz, Graham A.
    Toriola, Adetunji T.
    JAMA NETWORK OPEN, 2022, 5 (02)